"We are committed to providing Salt Lake City with the most advanced cardiology treatment options"

During the past decade, Heart Center at St. Mark's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Center at St. Mark's Hospital" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Heart Center at St. Mark's Hospital" are "Cardiovascular Disease" (2 trials), "Atherosclerosis" (1 trials), "Congestive Heart Failure" (1 trials), "Coronary Artery Disease" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Heart Center at St. Mark's Hospital" in a lesser frequency.

Most popular intervention types in "Heart Center at St. Mark's Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "AGI-1067" (1 trials), "carvedilol controlled release" (1 trials) and "carvedilol immediate release" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Center at St. Mark's Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Heart Center at St. Mark's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Heart Center at St. Mark's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Heart Center at St. Mark's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".